Mutation at the site of Ser624→Ala624 of FAPα resulted in ~100,000-fold decrease in DPP activity and attenuated tumor growth when HEK293 cells transfected with enzymatic mutant (S624A) FAPα were inoculated subcutaneously into a CB17-SCID mouse (27). The gene discussed is FAP; the disease is neoplasm.